INHIBIKASE THERAPEUTICS INC (IKT) Top Institutional Shareholders
INHIBIKASE THERAPEUTICS INC (IKT) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $190.58M in IKT holdings during the latest filing period.
Sands Capital Alternatives, Llc is currently the largest disclosed institutional shareholder of IKT tracked by InsiderSet, reporting ownership valued at approximately $21.87M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $21.87M, representing an estimated gain of +0.00% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 66% of the total disclosed IKT value among the investors covered in this analysis. Major shareholders include Sands Capital Alternatives, Llc, Soleus Capital Management, L.P., Fairmount Funds Management Llc, and several other long-term asset managers with concentrated positions in INHIBIKASE THERAPEUTICS INC (IKT).
This page ranks the largest institutional IKT shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
102
Total Reported Value
$190.58M
Largest Holder
Sands Capital Alternatives, Llc
Largest Position
$21.87M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
111
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Sands Capital Alternatives, Llc | 5.19% | 13,018,965 | $21,871,861 | $21,871,861 | +$0 | +0.00% | |
| Soleus Capital Management, L.P. | 0.74% | 10,875,000 | $18,270,000 | $18,270,000 | $0 | 0.00% | |
| Fairmount Funds Management Llc | 1.05% | 8,625,000 | $14,490,000 | $14,490,000 | $0 | 0.00% | |
| Trails Edge Capital Partners, Lp | 3.19% | 8,057,345 | $13,536,340 | $13,536,340 | -$0 | -0.00% | |
| Adar1 Capital Management, Llc | 0.67% | 6,606,572 | $11,099,041 | $11,099,041 | -$0 | -0.00% | |
| Blackrock, Inc. | 0.00% | 6,303,433 | $10,589,768 | $10,589,767 | -$1 | -0.00% | |
| Blackstone Inc. | 0.04% | 5,938,276 | $9,976,304 | $9,976,304 | -$0 | -0.00% | |
| Siren, L.L.C. | 0.27% | 5,850,000 | $9,828,000 | $9,828,000 | $0 | 0.00% | |
| Commodore Capital Lp | 0.52% | 5,397,488 | $9,067,780 | $9,067,780 | -$0 | -0.00% | |
| Vanguard Capital Management Llc | 0.00% | 4,450,665 | $7,477,117 | $7,477,117 | +$0 | +0.00% | |
| Saturn V Capital Management Lp | 1.18% | 3,863,445 | $6,490,588 | $6,490,588 | -$0 | -0.00% | |
| Spruce Street Capital Lp | 1.45% | 3,581,603 | $6,017,093 | $6,017,093 | +$0 | +0.00% | |
| Squadron Capital Management Llc | 2.35% | 3,500,000 | $5,880,000 | $5,880,000 | $0 | 0.00% | |
| Millennium Management Llc | 0.00% | 2,928,077 | $4,919,169 | $4,919,169 | +$0 | +0.00% | |
| Nantahala Capital Management, Llc | 0.28% | 2,701,863 | $4,539,130 | $4,539,130 | -$0 | -0.00% | |
| Kalehua Capital Management Llc | 3.79% | 2,672,608 | $4,489,981 | $4,489,981 | +$0 | +0.00% | |
| Perceptive Advisors Llc | 0.08% | 2,315,000 | $3,889,200 | $3,889,200 | $0 | 0.00% | |
| Geode Capital Management, Llc | 0.00% | 2,170,186 | $3,646,792 | $3,645,912 | -$880 | -0.02% | |
| State Street Corp | 0.00% | 1,685,816 | $2,832,171 | $2,832,171 | -$0 | -0.00% | |
| Summittx Capital, L.P. | 0.08% | 1,524,536 | $2,561,220 | $2,561,220 | +$0 | +0.00% | |
| Integral Health Asset Management, Llc | 0.12% | 1,350,000 | $2,268,000 | $2,268,000 | $0 | 0.00% | |
| Ally Bridge Group (Ny) Llc | 2.21% | 1,325,000 | $2,226,000 | $2,226,000 | $0 | 0.00% | |
| Citadel Advisors Llc | 0.00% | 1,102,585 | $1,852,343 | $1,852,343 | -$0 | -0.00% | |
| Stonepine Capital Management, Llc | 1.43% | 957,202 | $1,608,099 | $1,608,099 | +$0 | +0.00% | |
| Two Sigma Investments, Lp | 0.00% | 847,611 | $1,423,986 | $1,423,986 | +$0 | +0.00% | |
| Northern Trust Corp | 0.00% | 718,800 | $1,207,584 | $1,207,584 | $0 | 0.00% | |
| Vanguard Portfolio Management Llc | 0.00% | 617,730 | $1,037,786 | $1,037,786 | +$0 | +0.00% | |
| Vanguard Fiduciary Trust Co | 0.00% | 566,999 | $952,558 | $952,558 | +$0 | +0.00% | |
| Nuveen, Llc | 0.00% | 472,399 | $793,630 | $793,630 | +$0 | +0.00% | |
| Seven Fleet Capital Management Lp | 0.17% | 325,600 | $547,008 | $547,008 | $0 | 0.00% | |
| Bank Of America Corp | 0.00% | 322,704 | $542,143 | $542,143 | -$0 | -0.00% | |
| Charles Schwab Investment Management Inc | 0.00% | 235,414 | $395,496 | $395,496 | -$0 | -0.00% | |
| Ubs Group Ag | 0.00% | 228,151 | $383,293 | $383,294 | +$1 | +0.00% | |
| Rangeley Capital, Llc | 0.40% | 220,000 | $369,600 | $369,600 | $0 | 0.00% | |
| Bank Of New York Mellon Corp | 0.00% | 213,208 | $358,189 | $358,189 | +$0 | +0.00% | |
| Aqr Capital Management Llc | 0.00% | 172,013 | $288,982 | $288,982 | -$0 | -0.00% | |
| Morgan Stanley | 0.00% | 164,259 | $275,956 | $275,955 | -$1 | -0.00% | |
| Blair William & Co/Il | 0.00% | 157,988 | $265,420 | $265,420 | -$0 | -0.00% | |
| Goldman Sachs Group Inc | 0.00% | 149,857 | $251,760 | $251,760 | -$0 | -0.00% | |
| Deutsche Bank Ag\ | 0.00% | 122,442 | $205,703 | $205,703 | -$0 | -0.00% | |
| Fmr Llc | 0.00% | 71,963 | $120,898 | $120,898 | -$0 | -0.00% | |
| Metlife Investment Management, Llc | 0.00% | 62,913 | $105,694 | $105,694 | -$0 | -0.00% | |
| Rhumbline Advisers | 0.00% | 58,717 | $98,639 | $98,645 | +$6 | +0.01% | |
| Mirae Asset Global Etfs Holdings Ltd. | 0.00% | 50,284 | $84,477 | $84,477 | +$0 | +0.00% | |
| Sei Investments Co | 0.00% | 47,962 | $80,576 | $80,576 | +$0 | +0.00% | |
| New York State Common Retirement Fund | 0.00% | 47,900 | $80,472 | $80,472 | $0 | 0.00% | |
| Wells Fargo & Company/Mn | 0.00% | 40,531 | $68,092 | $68,092 | +$0 | +0.00% | |
| Point72 Asset Management, L.P. | 0.00% | 40,383 | $67,843 | $67,843 | +$0 | +0.00% | |
| Xtx Topco Ltd | 0.00% | 38,914 | $65,376 | $65,376 | -$0 | -0.00% | |
| Vanguard Global Advisers, Llc | 0.00% | 36,546 | $61,397 | $61,397 | +$0 | +0.00% |
Frequently asked questions about IKT
Who owns the most IKT stock?
The largest holders of IKT are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for INHIBIKASE THERAPEUTICS INC (IKT).
Is IKT widely held by superinvestors?
Many widely followed stocks like IKT appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly IKT is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.